• 1
    Thom T, Haase N, Rosamond W, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85e151.
  • 2
    Yusuf S, Hawken S, Ounpuu S, et al.; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937952.
  • 3
    Opie LH. The Metabolic Syndrome. Circulation. 2007;115:e32e35.
  • 4
    Lakka HM, Laasksonen DE, Lakka TA, et al. The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:27092716.
  • 5
    Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:68389.
  • 6
    Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis. 2004;173:309314.
  • 7
    Girman CJ, Rhodes T, Mercury M, et al.; The 4S group, the AFCAPS/Texas research group. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and Air Force/Texas Coronary Atherosclerosis Prevention Study. Am J Cardiol. 2004;93:136141.
  • 8
    Stern MP, Williams K, González-Villalpando C, et al. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004;27:26762681.
  • 9
    Albeit KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539553.
  • 10
    Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:24862497.
  • 11
    Oh JY, Hong YS, Sung YA. Prevalence and factor analysis of metabolic syndrome in urban Korean population. Diabetes Care. 2004;27:20272032.
  • 12
    Gang H, Qiao Q, Tuomilehto J, et al.; for DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all case and cardiovascular mortality in nom diabetic European men and women. Arch Intern Med. 2004;164:10661076.
  • 13
    Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet. 2005;366:10591062.
  • 14
    Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88:24602470.
  • 15
    Levey A, Bosch J, Lewis JB, et al. A more accurate method to estimate glomerular filtrations rate from serum creatinin: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461470.
  • 16
    National Cholesterol Education Program, National Heart, Lung and Blood Institute, National Institutes of Health. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation. 2002;106:31433421.
  • 17
    Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition: a consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469480.
  • 18
    Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:27452749.
  • 19
    Lorenzo C, Willians K, Hunt K, et al. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007;30:813.
  • 20
    Katzmarzyk PT, Janssen I, Ross R, et al. The importance of waist circumference in definition of metabolic syndrome. Diabetes Care. 2006;29:404984.
  • 21
    Eckel RH, Grundy SM, Zimmet PZ. The Metabolic Syndrome. Lancet. 2005;366:19231923.
  • 22
    Nilsson PM, Engstron G, Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects—a population-based study comparing three different definitions. Diabet Med. 2007;24:464472.
  • 23
    International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at: Accessed April 9, 2010..
  • 24
    Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280:18431848.
  • 25
    Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356359.
  • 26
    Meigs JB, Wilson PW, Nathan DM, et al. Prevalence and characteristics of the metabolic syndrome in the Santo Antonio Heart and Framingham Offspring Studies. Diabetes. 2003;52:21602167.
  • 27
    Resnick HE, Jones K, R’uotolo G, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in non diabetics American Indians: the Strong Heart Study. Diabetes Care. 2003;26:861867.
  • 28
    Snehatala C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care. 2003;26:13801384.
  • 29
    Tan CE, Ma S, Wai D, et al. Can we apply The NCEP definition of metabolic syndrome in Asians? Diabetes Care. 2004;27:182186.
  • 30
    Bruno G, Merlleti F, Biggeri A, et al.; Casale Monferrato Study. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care. 2004;27:26892694.
  • 31
    Cull AC, Jensen CC, Retnakaran R, et al. Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus. Circulation. 2007;116:21192126.